Format

Send to

Choose Destination
J Pediatr Hematol Oncol. 2008 Nov;30(11):860-4. doi: 10.1097/MPH.0b013e31818a953e.

Transient myeloproliferative disorder in neonates with and without Down syndrome: a tale of 2 syndromes.

Author information

1
Division of Pediatric Hematology/Oncology and Stem Cell Transplantation, Schneider Children's Hospital, New Hyde Park, NY, USA. napollonsky@yahoo.com

Abstract

Transient myeloproliferative disorder (TMD) in newborns with Down syndrome (DS) has been well described. We report 4 newborns, 2 with DS and 2 without DS, who developed TMD. One newborn with DS developed multiorgan failure and died despite treatment with low-dose cytarabine. In 3 newborns, the TMD resolved spontaneously. Two of these patients, 1 with and 1 without DS developed leukemia on subsequent follow-up and were treated successfully. We reviewed the clinical and laboratory data on 14 non-DS infants with TMD reported in the literature. According to limited data, these patients are more likely to develop leukemia than DS patients, however their outcome is better.

PMID:
18989165
DOI:
10.1097/MPH.0b013e31818a953e
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center